No new safety concerns were revealed, which may lead to the introduction of oral forms of Ozempic and Wegovy
From oral formulations to agonist combinations, from muscle preservation to indication expansion, the question remains: who will be the next company to bring a GLP-1-based therapeutic to the market
Beyond sleep disturbances, retatrutide carries a side effect profile broadly consistent with other agents in the incretin-based drug class
Pregnancy planning : If you're planning pregnancy, discuss discontinuation timing with your provider
Despite their effectiveness, GLP-1 therapies are not without limitations
Clinical Trials Focused on Weight Loss and Metabolic Health Most of the large studies on semaglutide were designed to measure weight loss, blood sugar control, and cardiovascular health